Page 10 - Joint Sponsors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joint sponsors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joint Sponsors Today - Breaking & Trending Today

TodayIR: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK

TodayIR: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK
DJ EQS-News: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK EQS-News / 29/04/2021 / 12:16 UTC+8 Zhaoke Ophthalmology(6622) Successfully Listed on Main Board of SEHK
[April 29, 2021, Hong Kong] Zhaoke Ophthalmology Limited ( Zhaoke Ophthalmology or the Company ; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, was successfully listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ( SEHK ) today.
Goldman Sachs (Asia) L.L.C., and Jefferies Hong Kong Limited are the Joint Sponsors, Joint Representatives, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers. ....

Hong Kong , Li Xiaoyi , Lee Pharm , Kostenloser Wertpapierhandel , Goldman Sachs Asia , Marketing Press , Jefferies Hong Kong , Stock Exchange Of Hong Kong Limited , Zhaoke Ophthalmology , Zhaoke Ophthalmology Limited , Main Board , Successfully Listed , Ophthalmology Limited , Stock Exchange , Hong Kong Limited , Jefferies Hong Kong Limited , Joint Sponsors , Joint Representatives , Joint Global Coordinators , Joint Bookrunners , Joint Lead , Executive Director , Marketing Press Release , Dow Jones Newswires , ஹாங் காங் , லீ பார்ம் ,

TodayIR: Zhaoke Ophthalmology Limited (6622) Announces Global Offering Results

DJ EQS-News: Zhaoke Ophthalmology Limited (6622) Announces Global Offering Results EQS-News / 28/04/2021 / 22:01 UTC+8 Zhaoke Ophthalmology(6622) Announces Global Offering Results Final Offer Price ....

Hong Kong , Li Xiaoyi , Kostenloser Wertpapierhandel , Goldman Sachs Asia , Marketing Press , Jefferies Hong Kong , International Offer , Zhaoke Ophthalmology , Zhaoke Ophthalmology Limited , International Offering , Announces Global Offering Results , Offer Share Listing , Main Board , Hong Kong Stock Exchange On April , Ophthalmology Limited , Stock Exchange , Hong Kong Limited , Kong Stock , Hong Kong Offer Shares , Kong Offer Shares , Offer Shares , Cornerstone Investment Agreement , Cornerstone Investor , Cornerstone Investors , Global Offering , Over Allotment Option ,

Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final

Zhaoke Ophthalmology is an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs in China. Leveraging its deep domain expertise while designing the pipeline, the Company has initially placed strategic emphasis on five major ophthalmic indications in China in terms of market potential, including dry eye disease, or DED, wet age-related macular degeneration, or wAMD, diabetic macular edema, or DME, myopia and glaucoma. Up to now, the Company has built a comprehensive ophthalmic drug pipeline of 25 candidates that covers most major ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. ....

United States , Hong Kong , Li Xiaoyi , Goldman Sachs Asia , Matthews International Capital Management , Golden Valley Global , Jefferies Hong Kong , International Placing , Zhaoke Ophthalmology , Orbimed Genesis Master Fund , Orbimed Partners Master Fund , Zhaoke Investment Fund , Hong Kong Zhaoke Ophthalmology Limited , Caas Capital Master Fund , Company Nansha , Jennison Associates , Stock Exchange Of Hong Kong Limited , Mass Ave Global Inc , Zhaoke Ophthalmology Limited , Launches Its , Fuel Its Future , Main Board , Stock Exchange , Hong Kong Limited , Jefferies Hong Kong Limited , Joint Sponsors ,

TodayIR: Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final

TodayIR: Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK Final
DJ EQS-News: Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK Final EQS-News / 16/04/2021 / 11:26 UTC+8 Zhaoke Ophthalmology Limited (6622.HK) Launches Its HKPO with 8 Cornerstone Investors to Fuel Its Future Growth
(April 16, 2021, Hong Kong) Zhaoke Ophthalmology Limited ( Zhaoke Ophthalmology or the Company ; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ( SEHK ) today. Goldman Sachs (Asia) L.L.C., and Jefferies Hong Kong Limited are the Joint Sponsors, Joint Representatives, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers. ....

United States , Hong Kong , Li Xiaoyi , Kostenloser Wertpapierhandel , Goldman Sachs Asia , Matthews International Capital Management , Golden Valley Global , Jefferies Hong Kong , International Placing , Zhaoke Ophthalmology , Zhaoke Investment Fund , Hong Kong Zhaoke Ophthalmology Limited , Company Nansha , Jennison Associates , Marketing Press , Orbimed Genesis Master Fund , Orbimed Partners Master Fund , Caas Capital Master Fund , Stock Exchange Of Hong Kong Limited , Mass Ave Global Inc , Zhaoke Ophthalmology Limited , Announces Proposed Listing , Main Board , Ophthalmology Limited , Launches Its , Fuel Its Future Growth ,

JD.com To Carve-Out Its Logistics Business Via IPO

JD.com To Carve-Out Its Logistics Business Via IPO
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Jd Group , Company Website , Inc Parent , International Offering , Jingdong Digits Technology Holding Co Ltd , Hong Kong Stock Exchange , Company Description , Jd Logistics Group , Jd Health , Market Capitalization , Main Board , Hong Kong Stock , Global Offering , Hong Kong Public Offering , Joint Sponsors , Proposed Spin Off , Potential Spin , Listing Committee , Fortune Global , Jd Com , Jd Com To Carve Out , Jd Com Inc , Spin Off Research , ஹாங் காங் , ஜ்ட் குழு ,